Literature DB >> 29438536

Evaluation of Xpert MTB/RIF Assay for Diagnosis of Tuberculosis in Children.

Arghya Das1, Shampa Anupurba1, Om P Mishra2, Tuhina Banerjee1, Rajneesh Tripathi1.   

Abstract

Introduction: Childhood tuberculosis (TB) is now a global priority. With the advent of Xpert MTB/RIF, more TB cases in children are being reported. This study was undertaken to evaluate the performance of Xpert in diagnosis of pulmonary and extra-pulmonary TB in children.
Methods: Specimens from 171 suspected TB cases in children aged <15 years were tested with Xpert, culture and smear microscopy in the Department of Microbiology, Institute of Medical Sciences, India.
Results: The specimens included 106 gastric aspirates, 51 cerebrospinal fluids, 8 induced sputum and 6 lymph node aspirates. Xpert detected Mycobacterium tuberculosis in 19 cases (14 pulmonary and 5 extra-pulmonary), 7 of which were rifampicin-resistant. Sensitivity, specificity, positive predictive value and negative predictive value of Xpert compared with culture were 88.89, 98.04, 84.21 and 98.68%, respectively. The sensitivity was 100% in children aged 1-5 years and 6-10 years and in gastric aspirates.
Conclusion: Xpert is an efficient diagnostic tool in childhood tuberculosis.

Entities:  

Year:  2019        PMID: 29438536     DOI: 10.1093/tropej/fmy005

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  8 in total

1.  Diagnostic accuracy of Xpert MTB/RIF for tuberculous meningitis: systematic review and meta-analysis.

Authors:  Adrian V Hernandez; Laryssa de Laurentis; Isadora Souza; Marcelo Pessanha; Priyaleela Thota; Yuani M Roman; Joshuan Barboza-Meca; David R Boulware; Jose E Vidal
Journal:  Trop Med Int Health       Date:  2020-11-30       Impact factor: 2.622

2.  Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Mandy Yao; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

3.  Evaluation of an in-house loop-mediated isothermal amplification for Mycobacterium tuberculosis detection in a remote reference laboratory, Thailand.

Authors:  Nasron Jekloh; Pisuttida Keawliam; Daris Mukem; Janisara Rudeeaneksin; Sopa Srisungngam; Supranee Bunchoo; Wiphat Klayut; Payu Bhakdeenaun; Benjawan Phetsuksiri
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-09-30       Impact factor: 2.169

4.  Difficulties with the implemented xpert MTB/RIF for determining diagnosis of pulmonary and extrapulmonary tuberculosis in adults and children.

Authors:  Ni Made Mertaniasih; Tutik Kusmiati; Eko Budi Koendhori; Deby Kusumaningrum; Titiek Sulistyowati; Zakiyathun Nuha; Hatif Chanifah
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-03-13

5.  Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.

Authors:  Birgit Schramm; Rodrigue C Nganaboy; Piex Uwiragiye; Didier Mukeba; Aboubacar Abdoubara; Illa Abdou; Jean-Claude Nshimiymana; Seyni Sounna; Laurent Hiffler; Laurence Flevaud; Helena Huerga
Journal:  PLoS One       Date:  2021-05-05       Impact factor: 3.240

Review 6.  Xpert MTB/RIF Assay for the Diagnosis of Lymph Node Tuberculosis in Children: A Systematic Review and Meta-Analysis.

Authors:  Hao-Kai Chen; Rui-Si Liu; Yi-Xuan Wang; En-Xiang Quan; Yuan-Hua Liu; Xu-Guang Guo
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

7.  Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.

Authors:  Alexander W Kay; Lucia González Fernández; Yemisi Takwoingi; Michael Eisenhut; Anne K Detjen; Karen R Steingart; Anna M Mandalakas
Journal:  Cochrane Database Syst Rev       Date:  2020-08-27

8.  Xpert MTB/RIF assay for diagnosis of extrapulmonary tuberculosis in children: a systematic review and meta-analysis.

Authors:  Young Seok Seo; Ji-Man Kang; Dong Soo Kim; Jong Gyun Ahn
Journal:  BMC Infect Dis       Date:  2020-01-06       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.